Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Burris

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
Nutrition (Burbank, Los Angeles County, Calif.)|July 3, 2014
Artemisia extracts activate PPARγ, promote adipogenesis, and enhance insulin sensitivity in adipose tissue of obese miceAllison J Richard, Thomas P Burris, David Sanchez-Infantes, et al.
ACS Central Science|March 4, 2024
From Functional Fatty Acids to Potent and Selective Natural-Product-Inspired Mimetics via Conformational ProfilingLauren E Markham, Thomas Koelblen, Harry R Chobanian, et al.
ACS Chemical Biology|December 15, 2012
A liver-selective LXR inverse agonist that suppresses hepatic steatosisKristine Griffett, Laura A Solt, Bahaa El-Dien M El-Gendy, et al.
Chembiochem : a European Journal of Chemical Biology|October 14, 2005
Potent inhibitors of LXXLL-based protein-protein interactionsAmit K Galande, Kelli S Bramlett, John O Trent, et al.
Molecular Metabolism|April 2, 2015
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitisKristine Griffett, Ryan D Welch, Colin A Flaveny, et al.
The Prostate|February 28, 2017
Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse ModelQiuyang Zhang, Sen Liu, Dongxia Ge, et al.
Bioorganic Chemistry|December 13, 2021
Synthesis and structure activity relationship of the first class of LXR inverse agonistsBahaa Elgendy, Kristine Griffett, Lamees Hegazy, et al.
Journal of Medicinal Chemistry|July 14, 2018
Recent Advances in the Medicinal Chemistry of Liver X ReceptorsBahaa El-Dien M El-Gendy, Shaimaa S Goher, Lamees S Hegazy, et al.
Biochemical and Biophysical Research Communications|June 3, 2023
Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblastsChandrashekhar Prasad, Kameron Hahn, Santosh Kumar Duraisamy, et al.
Molecular Pharmacology|September 26, 2008
The selective Alzheimer's disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target geneYongjun Wang, Pamela M Rogers, Keith R Stayrook, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
Nutrition (Burbank, Los Angeles County, Calif.)|July 3, 2014
Artemisia extracts activate PPARγ, promote adipogenesis, and enhance insulin sensitivity in adipose tissue of obese miceAllison J Richard, Thomas P Burris, David Sanchez-Infantes, et al.
ACS Central Science|March 4, 2024
From Functional Fatty Acids to Potent and Selective Natural-Product-Inspired Mimetics via Conformational ProfilingLauren E Markham, Thomas Koelblen, Harry R Chobanian, et al.
ACS Chemical Biology|December 15, 2012
A liver-selective LXR inverse agonist that suppresses hepatic steatosisKristine Griffett, Laura A Solt, Bahaa El-Dien M El-Gendy, et al.
Chembiochem : a European Journal of Chemical Biology|October 14, 2005
Potent inhibitors of LXXLL-based protein-protein interactionsAmit K Galande, Kelli S Bramlett, John O Trent, et al.
Molecular Metabolism|April 2, 2015
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitisKristine Griffett, Ryan D Welch, Colin A Flaveny, et al.
The Prostate|February 28, 2017
Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse ModelQiuyang Zhang, Sen Liu, Dongxia Ge, et al.
Bioorganic Chemistry|December 13, 2021
Synthesis and structure activity relationship of the first class of LXR inverse agonistsBahaa Elgendy, Kristine Griffett, Lamees Hegazy, et al.
Journal of Medicinal Chemistry|July 14, 2018
Recent Advances in the Medicinal Chemistry of Liver X ReceptorsBahaa El-Dien M El-Gendy, Shaimaa S Goher, Lamees S Hegazy, et al.
Biochemical and Biophysical Research Communications|June 3, 2023
Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblastsChandrashekhar Prasad, Kameron Hahn, Santosh Kumar Duraisamy, et al.
Molecular Pharmacology|September 26, 2008
The selective Alzheimer's disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target geneYongjun Wang, Pamela M Rogers, Keith R Stayrook, et al.
Pageof 17